• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

    64.75 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 198
    Open 64.75
    Bid (Size) 64.00 (500)
    Ask (Size) 66.00 (500)
    Prev. Close 64.75
    Today's Range 64.75 - 64.75
    52wk Range 13.22 - 94.90
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗
    Structure Therapeutics develops oral drugs for chronic diseases, with lead assets targeting diabetes, obesity, and cardiovascular care. 
    Via The Motley Fool

    Performance

    YTD
    -4.9%
    -4.9%
    1 Month
    -27.7%
    -27.7%
    3 Month
    +80.8%
    +80.8%
    6 Month
    +238.3%
    +238.3%
    1 Year
    +225.7%
    +225.7%

    More News

    Read More
    News headline image
    Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗
    Via Stocktwits
    News headline image
    The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
    Via The Motley Fool
    News headline image
    Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    This Healthcare Company Believes Its GLP-1 Pill Could Be "Next in Line" After Novo Nordisk and Eli Lilly. Its Valuation Is a Fraction of Theirs. ↗
    Via The Motley Fool
    News headline image
    A 10% Owner Of Structure Therapeutics Shed Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Can This Stock Double Again in 2026? ↗
    Via The Motley Fool
    News headline image
    The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗
    Via Stocktwits
    News headline image
    Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    The Case for Small-Cap Diversification: Why Investors are Looking Beyond Mega-Cap Tech
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
    Via MarketMinute
    Topics Economy
    News headline image
    The Great Rotation: Small-Caps Seize the Spotlight as Mega-Cap Fatigue Sets In
    Via MarketMinute
    Topics Economy
    News headline image
    The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    The Great Rotation: Small-Caps Break Out as Russell 2000 Hits Record Highs in Late 2025
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Why Structure Therapeutics Stock Doubled and Then Some on Monday ↗
    Via The Motley Fool
    News headline image
    Global Markets Brace for Fed Decision Amidst Divergent Policies and Geopolitical Crosscurrents
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants
    From Structure Therapeutics Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?
    Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.
    What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?
    Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?
    The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market
    What is the current price of Structure Therapeutics Inc. - American Depositary Shares?
    The current price of Structure Therapeutics Inc. - American Depositary Shares is 64.75
    When was Structure Therapeutics Inc. - American Depositary Shares last traded?
    The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 02/26/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.